Semaglutide Cost Guide: What GLP-1 Therapy Really Costs

Semaglutide costs about $1,000 to $1,350 a month at list price for branded Wegovy or Ozempic, but most people in the US pay far less: roughly $349 to $499 a month through Novo Nordisk’s NovoCare self-pay program, as little as $25 a month with a manufacturer savings card on commercial insurance, or a $25 to $100+ copay when a plan covers it. Compounded semaglutide, once $100 to $300 a month, is now legally restricted because the FDA declared the semaglutide shortage resolved in early 2025.

Below is a clear breakdown of what each path actually costs, why the numbers differ so much, and how to lower the bill.

Semaglutide is the active ingredient in three branded medications: Ozempic and Rybelsus (approved for type 2 diabetes) and Wegovy (approved for weight management). What you pay depends less on the drug itself and more on which product you get, whether insurance is involved, and which discount program you qualify for. Prices in this space change often, so treat every figure here as a current range rather than a fixed quote.

Semaglutide belongs to the GLP-1 receptor agonist class, often shortened to GLP-1 medications. It mimics the gut hormone glucagon-like peptide-1, which slows stomach emptying, lowers appetite and helps the pancreas release insulin when blood sugar rises. It is prescribed for type 2 diabetes, chronic weight management in adults with obesity or overweight, and, for Wegovy, cardiovascular risk reduction.

At a glance: semaglutide cost by option

For most US patients, the realistic monthly cost of semaglutide is $25 to $100+ with coverage or a savings card, and about $349 to $499 when paying cash through the manufacturer. The list price matters mainly as the starting point that deductibles and coinsurance are calculated from.

Semaglutide products, doses and how they are taken

The three semaglutide brands differ in form, approved use and dose schedule, and each of those affects the price you are quoted and whether insurance pays. The doses below are the standard labeled schedules; your prescriber sets the actual dose.

Does the semaglutide injection cost more at higher doses?

The semaglutide injection cost does not always rise with dose. Self-pay and telehealth programs sometimes charge more for higher strengths or for the maintenance phase, while some list prices are similar across strengths. Ask for the price at the dose you will reach after titration, not only the starting dose, because the first months at 0.25 mg are rarely what you pay long term.

Branded semaglutide list prices

The published list price for Wegovy and Ozempic has historically run from roughly $1,000 to $1,350 per month’s supply, depending on the product and package. Following pricing changes in early 2026, Novo Nordisk lowered certain self-pay reference prices, with figures around $675 per month cited for some products. The important point is that the list price is a starting number, not what most patients actually hand over at the pharmacy.

Ozempic and Wegovy contain the same molecule but are priced and covered differently because they carry different approved uses. That distinction matters a great deal for insurance, which we cover next.

The list price still reaches some patients directly. People on high-deductible plans pay it, or something close to it, until the deductible is met, and coinsurance is often a percentage of the list price rather than a flat copay. If your plan uses coinsurance, ask your insurer for the negotiated price so you can estimate your share.

What insurance does and does not cover

This is where costs vary the most.

• Type 2 diabetes: When semaglutide is prescribed for diabetes (Ozempic, Rybelsus), commercial and Medicare drug plans are more likely to cover it, often leaving a copay in the $25 to $100+ range. Coverage still depends on your specific formulary and any prior authorization requirements.
• Weight management: Coverage for Wegovy prescribed purely for weight loss is far less consistent. Many commercial plans exclude anti-obesity medications entirely, and traditional Medicare has historically not covered drugs used solely for weight loss. Some employer plans add this coverage as a benefit, so it is worth checking your own plan documents directly.

Before assuming anything, call the number on your insurance card and ask two specific questions: is this drug on the formulary for my prescribed use, and does it require prior authorization? A prescription that gets denied for weight loss may be approved when there is a documented diabetes or cardiovascular indication, which is a clinical decision for your prescriber, not a billing trick.

How much does semaglutide cost with insurance?

Semaglutide cost with insurance is usually a copay of about $25 to $100+ a month when the drug is on your formulary for the prescribed use. A commercially insured patient who also uses the manufacturer savings card may pay as little as $25. When the plan excludes the drug, insurance pays nothing and the self-pay price applies.

Medicare and Medicaid

Medicare Part D plans commonly cover Ozempic and Rybelsus for type 2 diabetes. In March 2024 the FDA approved Wegovy to reduce the risk of heart attack, stroke and cardiovascular death in adults with established cardiovascular disease and obesity or overweight, which gave Part D plans a non-weight-loss use to cover. Whether your plan does is a formulary question. Medicaid coverage of weight-management drugs is set state by state, and manufacturer savings cards cannot be used with either program.

Prior authorization and step therapy

Many plans that cover semaglutide require prior authorization: your prescriber submits records such as your diagnosis, body mass index, A1C or cardiovascular history. Some plans also require step therapy, meaning a trial of an older or cheaper medication such as metformin first. Approvals often expire after a set period and need renewal, so note the date.

Manufacturer savings cards and cash programs

Novo Nordisk runs savings programs that meaningfully change the math:

• Savings card (insured patients): People with commercial prescription coverage may pay as little as $25 per month, subject to a maximum monthly benefit cap. These cards generally exclude anyone on government insurance such as Medicare or Medicaid.
• Self-pay through NovoCare: For people paying cash, the manufacturer’s direct-pay pricing in 2026 has landed in the range of roughly $349 to $499 per month depending on the product and dose, with introductory pricing sometimes lower for the first fills. These offers change, and some promotional tiers have expiration dates, so confirm the current terms when you enroll.
• Patient assistance: Income-qualified patients without adequate coverage may be eligible for additional manufacturer assistance. Eligibility is specific and requires an application.

How the Ozempic savings card works in 2025 and 2026

The Ozempic savings card, like the Wegovy card, lowers the out-of-pocket cost for people whose commercial insurance covers the drug, down to as little as $25 a month up to a monthly benefit cap. It does not help when your plan excludes the drug entirely, and it cannot be combined with Medicare, Medicaid or other government coverage. Card terms are typically reset each year, so a card used in 2025 may carry different limits or an end date in 2026. Check the current terms before each refill year.

Telehealth and online pharmacy pricing

Telehealth platforms commonly advertise GLP-1 programs that bundle the prescription, clinical consults, and shipping into one monthly fee. For branded semaglutide, these programs typically reflect the manufacturer’s self-pay pricing plus the platform’s service layer, landing somewhere in the $200 to $500 per month range. Read carefully what is included. Some quotes cover only the consultation and route you to a pharmacy separately, while others bundle everything. Watch for auto-renewal terms and whether dose increases change the price.

Questions to ask a telehealth program before paying

• Is the medication branded semaglutide from a state-licensed pharmacy, or a compounded product?
• Does the monthly fee include the drug, or only the clinical visit?
• Does the price change when the dose increases?
• Who reviews side effects, and how quickly can you reach a licensed clinician?
• How do you cancel, and is there a minimum commitment?

The FDA’s consumer page on concerns with unapproved GLP-1 drugs used for weight loss lists telehealth red flags and recommends filling prescriptions at a state-licensed pharmacy.

Compounded semaglutide and the regulatory caveat

For a stretch in 2023 to 2024, compounded semaglutide was widely available at $100 to $300 per month because the branded drug was on the FDA’s official shortage list, which temporarily allowed compounding pharmacies to prepare it.

That window has largely closed. The FDA declared the semaglutide shortage resolved in early 2025 and set enforcement deadlines for compounders to wind down. By 2026 the agency moved further, proposing to keep semaglutide off the bulk compounding lists and issuing warning letters to compounding operations. The practical result:

• Large-scale (503B) production of compounded semaglutide for general distribution is no longer permitted.
• Smaller (503A) pharmacies face serious legal risk unless they can document a specific, patient-level medical need that the commercial product cannot meet, such as a documented allergy to an inactive ingredient.
• Marketing that presents compounded semaglutide as a routine cheaper substitute is a red flag. Be cautious of any seller promising easy, low-cost compounded semaglutide with no clinical justification.

If a provider offers compounded semaglutide, ask directly what legal basis applies to your situation and which licensed pharmacy is dispensing it. Honest programs can explain both. Because this area is actively in flux, verify the current FDA position before relying on a compounded product. For a fuller comparison of the molecules and how this affects choosing a medication, see our guides linked below.

According to the FDA, unapproved versions of GLP-1 drugs, including compounded semaglutide, do not undergo the agency’s review for safety, effectiveness and quality, and compounded drugs should only be used when an FDA-approved drug cannot meet a patient’s medical needs. Our compounded semaglutide treatment guide explains the 503A and 503B pharmacy categories and what to ask a prescriber in more depth.

HSA and FSA eligibility

Semaglutide prescribed and dispensed for an approved medical use is generally an eligible expense under a Health Savings Account or Flexible Spending Account, since it is a prescription medication. For weight management specifically, some plan administrators ask for a letter of medical necessity from your prescriber. Using pre-tax HSA or FSA dollars effectively discounts the medication by your marginal tax rate, which is one of the simpler ways to lower the real cost. Confirm the requirement with your plan administrator and keep your receipts.

What does a year of semaglutide cost?

A year of semaglutide costs roughly $4,200 to $6,000 at the $349 to $499 monthly self-pay range, and about $12,000 to $16,200 at the $1,000 to $1,350 list price. With a $25 savings card copay, the drug itself can come to about $300 a year. Those figures are simple multiplication of the monthly ranges above, before visit fees or lab work.

Why the timeline matters for cost

Semaglutide is generally prescribed as a long-term medication rather than a short course. In the STEP 1 trial, published by Wilding and colleagues in the New England Journal of Medicine (2021), adults taking 2.4 mg weekly for 68 weeks lost a mean 14.9% of body weight, compared with 2.4% on placebo. The STEP 1 trial extension (Wilding et al., Diabetes, Obesity and Metabolism, 2022) found that participants regained about two-thirds of the weight they had lost within a year of stopping.

The real cost question is the monthly price multiplied by many months, so plan how you would keep paying if coverage changes.

Costs beyond the medication

• Clinical visits: An initial evaluation and follow-up visits with a primary care physician, endocrinologist, obesity medicine physician, nurse practitioner or physician assistant.
• Lab work: Baseline and follow-up tests such as A1C and kidney function.
• Nutrition and activity support: Many programs pair the medication with a registered dietitian or coaching, which may be billed separately.
• Side-effect management: Nausea, constipation and other gastrointestinal effects are common during dose increases. Our overview of semaglutide side effects and how they are handled covers what to expect.

Semaglutide vs tirzepatide and other GLP-1 options on cost

Tirzepatide (sold as Mounjaro for type 2 diabetes and Zepbound for weight management) is the main alternative to semaglutide. It acts on both GLP-1 and GIP receptors, follows the same pattern of high list price, manufacturer self-pay programs and uneven insurance coverage, and is likewise covered more often for diabetes than for weight loss. Our side-by-side comparison of semaglutide and tirzepatide covers effectiveness, dosing and side effects alongside price.

Compounded tirzepatide faces the same FDA restrictions after its shortage ended, as the compounded tirzepatide guide explains. Newer agents such as retatrutide are still investigational and not FDA approved, so any seller offering them outside a clinical trial is selling an unapproved product; the retatrutide overview summarizes where the research stands.

Where to find a clinician who prescribes semaglutide

Semaglutide is a prescription drug, so the first cost is a visit with a licensed prescriber. Primary care physicians, endocrinologists and obesity medicine specialists commonly prescribe it, and nurse practitioners and physician assistants can also prescribe it under rules that vary by state. Your existing primary care office is usually the simplest place to start, especially if you hope to use insurance.

Some regenerative and functional medicine clinics offer GLP-1 weight programs alongside peptide-based care. You can browse the national list of peptide therapy clinics to compare clinics that offer medically supervised metabolic programs, and read the peptide therapy treatment guide for how these clinics typically work. Ask any clinic whether it prescribes branded semaglutide, what is included in its fee and how often a clinician reviews your progress.

Regenerated.com is free for patients. Listing order on the directory is not paid ranking, Featured slots are labeled and capped, and Verified means credential checks, not spend; the guide to Featured, Verified and organic listings explains each label. Inclusion in the directory is not an endorsement, so confirm prescriber credentials and pharmacy sourcing yourself.

How to lower what you pay

• Check your formulary first. Coverage for your specific indication is the single biggest lever. Confirm it before paying cash for anything.
• Stack the right program. If you have commercial insurance, the savings card route is usually cheapest. If you are uninsured or excluded, compare the manufacturer’s self-pay price against telehealth bundles.
• Use HSA or FSA funds for the prescription to capture the tax advantage.
• Ask about dose timing. Costs and promotions sometimes differ by dose strength and by whether you are a new or continuing patient.
• Compare pharmacies. Cash prices and discount-card prices can differ between pharmacies for the identical product.
• Reassess every few months. Pricing, coverage rules, and program terms in this category change frequently.
• Appeal a denial with documentation. If prior authorization is denied, ask your prescriber whether a documented diabetes or cardiovascular indication supports an appeal.

Frequently asked questions

Why is the list price so much higher than what people actually pay?

The list price of about $1,000 to $1,350 a month is a published sticker number set before insurance, rebates and manufacturer discounts. Most patients pay through a savings card, the NovoCare self-pay program or an insurance copay, all of which sit well below list. The list price still matters on a high-deductible plan or with coinsurance, because your share is often calculated from it until the deductible is met.

Is compounded semaglutide still a cheap option in 2026?

For most people, no. The FDA declared the semaglutide shortage resolved in early 2025, which ended the broad legal basis for compounding it. Compounded semaglutide may still be prepared in limited, individually justified cases, such as a documented allergy to an ingredient in the branded product, but it is no longer a routine low-cost substitute. The FDA notes that compounded versions do not undergo its review for safety, effectiveness and quality.

Will my insurance cover semaglutide for weight loss?

Often not. Many commercial plans exclude anti-obesity medications such as Wegovy, and traditional Medicare has generally not covered drugs used solely for weight loss. Coverage is more common when semaglutide is prescribed for type 2 diabetes, and some Part D plans cover Wegovy for its cardiovascular risk reduction indication. Check your own plan’s formulary, prior authorization and step therapy rules before you fill the prescription.

Can I use my HSA or FSA to pay for semaglutide?

Generally yes, when semaglutide is a prescription for an approved medical use such as type 2 diabetes or weight management. Some plan administrators require a letter of medical necessity from your prescriber for weight management. Paying with pre-tax HSA or FSA dollars lowers the effective price by your marginal tax rate. Confirm the specifics with your plan and keep documentation of the prescription and every payment.

How much is semaglutide per month with insurance?

With insurance that covers it, semaglutide usually costs a copay of about $25 to $100+ per month. Adding the manufacturer savings card can bring a commercially insured patient down to as little as $25 a month, up to the card’s monthly cap. If your plan excludes the drug, insurance pays nothing and the NovoCare self-pay range of about $349 to $499 a month becomes the realistic price.

Is there an Ozempic savings card in 2026?

Novo Nordisk has continued to offer savings cards for Ozempic and Wegovy to people with commercial insurance, with costs as low as $25 a month up to a monthly benefit cap. The cards exclude Medicare, Medicaid and other government insurance, and they only help when your plan covers the drug. Terms are typically reset each year, so a card that worked in 2025 may carry different limits in 2026. Confirm the current terms before refilling.

Related reading

• Semaglutide vs tirzepatide
• Semaglutide side effects
• Tirzepatide for weight loss
• Peptide therapy
• How to protect muscle while taking a GLP-1
• Why GLP-1 weight loss plateaus

This article is for education only and is not medical or financial advice. Drug prices, insurance coverage, savings programs, and compounding regulations change frequently and vary by individual circumstance. Verify current pricing and coverage with the manufacturer, your pharmacy, and your insurer, and consult a licensed clinician before starting, stopping, or changing any medication.

Frequently Asked Questions: prices, products and payment

How much does semaglutide cost without insurance?

Without insurance, semaglutide costs about $349 to $499 a month through the manufacturer’s NovoCare self-pay program in 2026, against a list price of about $1,000 to $1,350 a month. Telehealth programs that bundle branded semaglutide with consults generally fall between $200 and $500 a month. Twelve months at the self-pay range comes to roughly $4,200 to $6,000 for the medication alone, before visit or lab fees.

What is the difference between Ozempic, Wegovy, and Rybelsus?

All three contain semaglutide but are approved for different uses. Ozempic is a once-weekly injection and Rybelsus a once-daily tablet, both approved for type 2 diabetes. Wegovy is a once-weekly injection approved for chronic weight management and, since March 2024, for cardiovascular risk reduction in adults with heart disease and obesity or overweight. Which one applies to you affects prescribing, dose and how likely insurance is to cover it.

Does insurance cover semaglutide?

It depends on why semaglutide is prescribed. When used for type 2 diabetes, it is more often covered by commercial and Medicare plans. For weight loss, many commercial plans exclude anti-obesity medications, and traditional Medicare has historically not covered drugs used solely for weight loss. When it is covered, copays typically range from $25 to $100 or more per month, often after prior authorization.

How much can a manufacturer savings card reduce the price?

If you have commercial insurance that covers semaglutide, a manufacturer savings card can bring the cost down to as low as $25 per month, up to a monthly benefit cap. This is separate from the NovoCare self-pay program, which is aimed at people paying cash rather than using insurance. Savings cards cannot be used with Medicare, Medicaid or other government coverage.

Is compounded semaglutide a reliable cheaper option?

Not any more for most people. Compounded semaglutide has been priced around $100 to $300 per month, but availability is now limited. The FDA declared the semaglutide shortage resolved in early 2025, so large-scale 503B compounding is prohibited and smaller 503A pharmacies face serious legal risk unless they can document patient-specific medical needs. Marketing that presents compounded semaglutide as a routine cheaper substitute is a red flag.

Can I use an HSA or FSA to pay for semaglutide?

Yes, semaglutide qualifies as an eligible HSA or FSA expense when it is prescribed for an approved use, because it is a prescription medication. For weight management, some plans require a letter of medical necessity from your prescriber before the expense is accepted. Using pre-tax dollars from either account lowers the effective cost by your marginal tax rate, so keep the prescription and receipts on file.